|
|
|
Pharmaceutical Manufacturing and Packing Sourcer
|
|
Billions of dollars are wasted each year due to healthcare solutions noncompliance. With the challenges healthcare budgets face (an ageing population and an increasing number of chronic conditions to name a few), how can patients better manage their health? While making a device connected is not a magic bullet to improve compliance and health, they present some clear benefits. How does one decide if a device should be smart, connected, or neither? Clear questions must be asked before deciding if a device should be connected or not. The categories of needs which define this include: engagement, competence, onboarding, re-onboarding, and more. These should be identified by exploring both connected and non-connected solutions, after which, the solutions to whether a product is connected or not becomes clearer.
In the regulated world of healthcare, the true cost of a connected solution is high and not just financially. Patient attitudes around sharing their health data must be considered, and the benefits they receive should be worthwhile for providing that information.
Understanding the Problem
Many stakeholders are involved in delivering and managing a patient’s therapy. These range from the patient, the caregivers, and healthcare professionals who deliver the care, through to the pharmacist who dispenses the therapy, the payer who funds it, and, not forgetting, the pharmaceutical company that developed it. Each of these stakeholders has different needs and desires, which may or may not be satisfied through the use of a connected medical device. For example, a pharma company may want to ensure that their clinical trials run smoothly so that the therapy is successful, effective, and meets the needs of the regulators. Healthcare professionals want better clinical outcomes for patients, and, ultimately, the patient wants to have their therapy funded and to be able to manage their condition successfully.
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
Charlotte Harris is a Senior Consultant at Team Consulting whose work typically focusses on managing the strategic and creative ‘front-end’ of the product development process. She has over 20 years’ experience in the medical device industry and has worked in clinical, start-up, and consultancy environments. Charlotte studied medical engineering and has a BEng from Cardiff University, UK, and an MSc from Kings College London, UK.
Tom Etheridge is an Industrial Design Consultant at Team Consulting who uses his experience to deliver holistic support to design, engineering, and human factors groups. He has a degree in industrial design technology from Brunel University, UK, and has worked in a design consultancy environment since graduating in 2010. Tom has been the lead industrial designer on several projects ranging from medical devices to consumer electronics.
Paul Greenhalgh heads Team Consulting’s design group. He is a passionate advocate of the importance of ‘good design’ and is involved in all stages of product development, from front-end innovation to detailed design for manufacture.
|
|
|
|
|
|
 |
News and Press Releases |
 |
AARDEX and Cambridge Cognition Join Forces to Bring Next-Level Adherence Oversight to Hybrid and Decentralized Clinical Trials
More info >> |
|
 |
White Papers |
 |
|
Speciality Logistics Outlook 2015
World Courier
To date, there are more than 178,000 registered clinical trials taking place across the globe, and global pharma’s volume has more than doubled over the last decade. With emerging markets showing explosive predictive growth through 2016, shippers and trial sponsors can expect continued regulatory and overall logistics complexities that foster demand for local, inmarket resources across the globe.
More info >> |
|
 |
Industry Events |
 |
The Pharmaceutical Manufacturing and Packaging Congress 2023 (PHARMAP 2023)
12-13 June 2023, Hilton Geneva Hotel & Conference Centre, Geneva, Switzerland
The Pharmaceutical Manufacturing and Packaging Congress 2023 (PHARMAP 2023) gathers top-level management from pharmaceutical
companies of manufacturing, primary and secondary packaging, purchasing,
and supply chain and procurement sectors, CMOs and CDMOs leaders, heads
from government and institution on 12-13, June, 2023 in Geneva,
Switzerland.
More info >> |
|
|
